USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Market Implications of the $1000 Genome: An Evolving Competitive Landscape
Vital Signs - Market Implications of the $1000 Genome: An Evolving Competitive Landscape
RELEASE DATE
03-Mar-2008
03-Mar-2008
REGION
North America
North America
Research Code: 9561-00-57-00-00
SKU: HC00518-NA-MR_03990
$1,500.00
In stock
SKU
HC00518-NA-MR_03990
Description
This issue of Vital Signs, released on March 3, 2008, provides an strategic overview of market implications of the $1000 Genome. Additionally, a company spotlight is provided for Pacific Biosciences, a biotechnology company developing a transformative single-molecule, real-time (SMRT) DNA sequencing platform. Reimbursement and regulatory news from the FDA is also provided for the week of February 18 - February 22, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on March 3, 2008, provides an strategic overview of market implications of the $1000 Genome. Additionally, a company spotlight is provided for Pacific Biosciences, a biotechnology company developing a transformative single-molecule, real-time (SMRT) DNA sequencing platform. Reimbursement and regulatory news from the FDA is also provided for the week of February 18 - February 22, 2008.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-57-00-00 |
| Is Prebook | No |